Literature DB >> 18653982

Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.

Surendra Karki1, Prakash Ghimire, Bishnu Raj Tiwari, Anil Maharjan, Manita Rajkarnikar.   

Abstract

In Nepal, hepatitis B and hepatitis C are considerable health problems. This study aimed to assess the trends of hepatitis B virus (HBV) and hepatitis C virus (HCV) seroprevalence in blood donors over the last 6 years nationwide and in the urbanized setting of Kathmandu Valley. This was a retrospective study conducted among Nepalese blood donors through the years 2001/2002-2006/2007. Serum samples were tested for hepatitis B surface antigen and anti-HCV antibodies using third generation ELISA tests. The donors' information was collected via the donor record register through their respective Blood Transfusion Services. The software, Winpepi ver 3.8 was used for statistical analysis. The overall seroprevalence rates of HBV and HCV in a nationwide analysis were observed to be 0.82 and 0.47%, respectively, and at Central Blood Transfusion Service (CBTS), Kathmandu, the rates were 0.92 and 0.71%, respectively. The seroprevalence of HBV was significantly higher than the seroprevalence of HCV, both nationwide and at CBTS (P < 0.05). An overall significantly decreasing trend was observed in HBV and HCV seroprevalence both nationwide and at CBTS, Kathmandu, over the last 6 years (P < 0.05). Though the overall trend was significantly decreasing, the test for departure from a linear trend also showed a statistically significant result (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653982

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  9 in total

1.  Seroprevalence of hepatitis B surface antigen, antibodies to the hepatitis C virus, and human immunodeficiency virus in a hospital-based population in jaipur, rajasthan.

Authors:  Smita Sood; Shirish Malvankar
Journal:  Indian J Community Med       Date:  2010-01

2.  Seroprevalence of HBV and HCV in blood donors: A study from regional blood transfusion services of Nepal.

Authors:  B R Tiwari; P Ghimire; S R Kandel; M Rajkarnikar
Journal:  Asian J Transfus Sci       Date:  2010-07

3.  Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal.

Authors:  Shyam Raj Upreti; Santosh Gurung; Minal Patel; Sameer M Dixit; L Kendall Krause; Geeta Shakya; Kathleen Wannemuehler; Rajesh Rajbhandari; Rajendra Bohara; W William Schluter
Journal:  Vaccine       Date:  2014-06-18       Impact factor: 3.641

4.  Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal.

Authors:  Sundar Khadka; Rupendra Shrestha; Sanjeet Pandit; Roshan Pandit; Anup Bastola
Journal:  Case Rep Med       Date:  2019-02-11

5.  Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.

Authors:  Hans-Tilmann Kinkel; Dibesh Karmacharya; Jivan Shakya; Sulochana Manandhar; Santosh Panthi; Prajwola Karmacharya; Deepika Sitaula; Reenu Thapaliya; Prawachan K C; Apurva Rai; Sameer Dixit
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

6.  Decrease in hepatitis B prevalence among blood donors in Central-West Brazil.

Authors:  Andréa de Siqueira Campos Lindenberg; Ana Rita Coimbra Motta-Castro; Marco Antonio Puga; Tayana Serpa Ortiz Tanaka; Marina Sawada Torres; Sonia Maria Fernandes-Fitts; Rivaldo Venancio Cunha
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-04-08

7.  Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.

Authors:  Manjula Bhattarai; Jagat Bahadur Baniya; Nirmal Aryal; Bimal Shrestha; Ramanuj Rauniyar; Anurag Adhikari; Pratik Koirala; Pardip Kumar Oli; Ram Deo Pandit; David A Stein; Birendra Prasad Gupta
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

Review 8.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06

9.  Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal.

Authors:  Sudhamshu Kc; Niyanta Karki; Dilip Sharma; Sandip Khadka; Pratap S Tiwari
Journal:  Cureus       Date:  2021-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.